Skip to content
WeighLab

Boston Medical Group vs Aquivia Health

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Boston Medical Group

Provider comparison

Cost-first shoppers who want a clinician-run 12-week program and can accept a price quoted as a range rather than a rate.

Semaglutide / month
$199/moStarting strength, rising with dose, compounded
Tirzepatide / month
Not disclosed
Index 56/100 · Grade CChecked October 2026

Aquivia Health

Provider comparison

Shoppers who want clinician-reviewed compounded GLP-1s with the option to move up to brand-name Ozempic or Zepbound.

Semaglutide / month
$249 per 4 weeksCompounded; $179 per shipment on a 52-week plan paid up front
Tirzepatide / month
$339 per 4 weeksCompounded; $269 per shipment on a 52-week plan paid up front
Index 55/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Boston Medical Group has the higher Cost-Efficiency Index: 56/100 versus 55/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Boston Medical Group
Weight-loss coverage not published
Aquivia Health
Coverage not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Boston Medical Group

Aquivia Health

Semaglutide / month
Boston Medical Group: $199/moStarting strength, rising with dose, compounded
Aquivia Health: $249 per 4 weeksCompounded; $179 per shipment on a 52-week plan paid up front
Tirzepatide / month
Boston Medical Group: Not disclosed
Aquivia Health: $339 per 4 weeksCompounded; $269 per shipment on a 52-week plan paid up front
Semaglutide / year (modeled)
Boston Medical Group: $2,388
Aquivia Health: $3,23713 charges
Tirzepatide / year (modeled)
Boston Medical Group: —
Aquivia Health: $4,40713 charges
State availability
Boston Medical Group: Weight-loss coverage not published
Aquivia Health: Coverage not published
Oral / sublingual option listed
Boston Medical Group: Not listed
Aquivia Health: Not listed
Brand-name access listed
Boston Medical Group: Not confirmed
Aquivia Health: Yes
Provider facts checked
Boston Medical Group: October 2026
Aquivia Health: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Boston Medical Group

Cost-first shoppers who want a clinician-run 12-week program and can accept a price quoted as a range rather than a rate.

Reasons to consider it

  • An established medical group with a defined 12-week program rather than an open-ended subscription
  • Public pages describe a twelve-week program and monthly shipments, but disagree on the price
  • Semaglutide is prescribed and dispensed under a compounded pathway with clinician oversight

What to weigh up

  • The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
  • The site quotes conflicting twelve-week totals: $699 on its cost page and $999 on its program-steps page, which separately names a $100 telemedicine platform fee; get a written all-in quote
  • The weight-loss landing page carries no price at all; the numbers are two pages deeper, in the FAQ and the costs page

Aquivia Health

Shoppers who want clinician-reviewed compounded GLP-1s with the option to move up to brand-name Ozempic or Zepbound.

Reasons to consider it

  • Clinical care provided by Open Loop Healthcare Partners, PC — a reused, verified MSO network
  • Named leadership: Steven Bishop MD (CMO), Phillip Gray PharmD (Chief Pharmacist), Tom Foster (President)
  • Publishes every plan price: compounded semaglutide is $249 and tirzepatide $339 per 4 weeks, less on 12-, 24- and 52-week plans, with Ozempic at $1,299 and Zepbound at $1,399 per fill

What to weigh up

  • Billed every 4 weeks, so a year is 13 charges, and the cheapest rates ($179 and $269 a shipment) need a 52-week plan paid in one $2,327 or $3,497 payment; the '$149/mo' and '$179/mo' cards above the plans carry an asterisk the page never explains
  • No public list of states served — you must complete intake to learn if your state qualifies
  • No named 503A compounding pharmacy partner, limiting licensure verification

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Boston Medical GroupAquivia Health
Normalized Cost/Month
Boston Medical Group:
45/100
Aquivia Health:
61/100
Price Transparency
Boston Medical Group:
78/100
Aquivia Health:
46/100
Nationwide Access
Boston Medical Group:
24/100
Aquivia Health:
24/100
Formulation Options
Boston Medical Group:
53/100
Aquivia Health:
79/100
Clinical Oversight
Boston Medical Group:
88/100
Aquivia Health:
76/100
Contract Flexibility
Boston Medical Group:
55/100
Aquivia Health:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.